Pharmacokinetics of potent antibiotics with Sustained Low Efficiency Dialysis in Intensive Care.

Not Applicable

Withdrawn

• Conditions: Acute Kidney Injury; Sepsis; Infection - Other infectious diseases; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12616000052437
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Any septic ICU patient, treated with meropenem or tazocin who requires SLED-HDF for the treatment of their acute kidney injury

Exclusion Criteria

The next of kin do not consent to particpation. (Rarely will the individual be able to give consent as they will be ventilated and sedated).
Intensivist deem the participant is not suitable for the study on clinical grounds.

Study & Design

• Study Type: Observational
• Study Design: Not specified